Olivia C. Coope
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olivia C. Coope has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Tilly J. Spurr
School of Sport, Science and Engineering, University of Chichester, College Lane, Chichester PO19 6PE, UK
5 shared publications - Blanca Roman-Viñas
Department of Physical Activity and Sport Sciences, Blanquerna Universitat Ramon Llull Barcelona Spain
4 shared publications - Alexander Levington
Strength and Nutrition Ltd., Brighton BN3 8PS, UK
3 shared publications - Beth Lloyd
Leiden University
3 shared publications Aina Domenech Farre
Seagull Academy Club Esportiu Seagull Barcelona Spain
1 shared publication- Alex Levington
Fulham FC Academy, Motspur Park, New Malden, Surrey KT3 6PT, UK
1 shared publication
Latest Publications
- Open Access
- 2 September 2026
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 23 (1)
Nutrition knowledge and dietary intake in male English Premier League academy players and their key stakeholders
1. Academy footballers in any English Premier League (EPL) Category 1 academies are divided into three age groups: Foundation Phase (FP) (U9s-U11s), YDP (U12s-U16s), and Professional Development Ph...
- 2 September 2026
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 23 (1)
Open AccessNutrition knowledge and dietary intake in male English Premier League academy players and their key stakeholders
1. Academy footballers in any English Premier League (EPL) Category 1 academies are divided into three age groups: Foundation Phase (FP) (U9s-U11s), YDP (U12s-U16s), and Professional Development Ph...
- Open Access
Health Behaviours in Soccer Support Staff: 24-Hour Movement Adherence Is Positively Associated with Diet Quality
Soccer support staff operate under demanding schedules and high-performance environments while guiding players’ movement, sleep, and nutrition; however, their own lifestyle behaviours remain under-researched. This exploratory study assessed adherence to the Canadian 24-Hour Movement (24HM) guidelines and its association with diet quality (DQ) in professional and semi-professional soccer support staff. Methods: A cross-sectional survey collected data from 236 staff in the United Kingdom and Spain. Movement behaviours were measured using the Whole Day Matters Toolkit and DQ using the validated Mini-EAT questionnaire. A graded 24HM score (0–8) summed binary adherence across four general (MVPA, LPA, sedentary time, sleep) and four secondary (muscle-strengthening, sedentary interruptions, screen time, sleep–wake time) behaviours. Associations with DQ were estimated using adjusted multiple linear regression. Results: Only 7.6% of participants met all eight guidelines. Each one-point increase in the graded score was associated with 0.89-point higher DQ (95% CI 0.29–1.49, p = 0.004), with stronger associations observed for secondary behaviours (β = 1.27, p = 0.006) than for general behaviours (β = 0.38, p = 0.50). Conclusions: A graded 24HM scoring approach showed a graded association with DQ in soccer staff, with secondary movement behaviours showing a stronger association. All findings should be interpreted as exploratory and hypothesis-generating. ClinicalTrials.gov: NCT06771752.
Open AccessHealth Behaviours in Soccer Support Staff: 24-Hour Movement Adherence Is Positively Associated with Diet Quality
Soccer support staff operate under demanding schedules and high-performance environments while guiding players’ movement, sleep, and nutrition; however, their own lifestyle behaviours remain under-researched. This exploratory study assessed adherence to the Canadian 24-Hour Movement (24HM) guidelines and its association with diet quality (DQ) in professional and semi-professional soccer support staff. Methods: A cross-sectional survey collected data from 236 staff in the United Kingdom and Spain. Movement behaviours were measured using the Whole Day Matters Toolkit and DQ using the validated Mini-EAT questionnaire. A graded 24HM score (0–8) summed binary adherence across four general (MVPA, LPA, sedentary time, sleep) and four secondary (muscle-strengthening, sedentary interruptions, screen time, sleep–wake time) behaviours. Associations with DQ were estimated using adjusted multiple linear regression. Results: Only 7.6% of participants met all eight guidelines. Each one-point increase in the graded score was associated with 0.89-point higher DQ (95% CI 0.29–1.49, p = 0.004), with stronger associations observed for secondary behaviours (β = 1.27, p = 0.006) than for general behaviours (β = 0.38, p = 0.50). Conclusions: A graded 24HM scoring approach showed a graded association with DQ in soccer staff, with secondary movement behaviours showing a stronger association. All findings should be interpreted as exploratory and hypothesis-generating. ClinicalTrials.gov: NCT06771752.
- Open Access
- 2 May 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (5) , 725
Back to the Roots: Safety and Tolerability of Standardised Ashwagandha (Withania somnifera) Root Extract in Healthy Adults—A Systematic Review of Biomarkers and Adverse Events
Background: Standardised Ashwagandha root extract (SARE), characterised by its content of bioactive withanolides, is widely used for its antioxidant and adaptogenic properties; however, recent case reports have raised safety concerns, primarily involving non-standardised or multi-ingredient formulations. This systematic review evaluated the safety and tolerability of SARE in healthy adults, with a focus on clinical biomarkers and adverse event reporting. Methods: Randomised trials were identified through searches of PubMed, Web of Science and Google Scholar, published from 2010 to April 2026. Studies administering single-ingredient, standardised root-only extracts to generally healthy populations were included. Risk of bias was assessed using the Cochrane RoB 2 tool. Results: Twenty-three studies with a total of 2317 participants met the inclusion criteria, with doses ranging from 125 to 600 mg/day and intervention durations from a single dose to 180 days. Across studies, hepatic, renal, haematological, endocrine, and cardiovascular biomarkers remained within normal clinical ranges, with no clinically meaningful adverse alterations reported. Reductions in cortisol were consistently observed, while increases in testosterone remained within physiological ranges. No serious adverse events attributable to SARE were reported. Mild adverse events, including gastrointestinal discomfort, headache, and transient drowsiness, were infrequently reported and occurred in both intervention and comparator groups. Conclusions: SARE was well tolerated in healthy adults at the studied doses and durations. However, limited long-term data (>180 days) and heterogeneity in study design and reporting warrant further large-scale, standardised trials to confirm safety across extended use and diverse populations. The review is registered in the PROSPERO database with ID CRD420261337116.
- 2 May 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (5) , 725
Open AccessBack to the Roots: Safety and Tolerability of Standardised Ashwagandha (Withania somnifera) Root Extract in Healthy Adults—A Systematic Review of Biomarkers and Adverse Events
Background: Standardised Ashwagandha root extract (SARE), characterised by its content of bioactive withanolides, is widely used for its antioxidant and adaptogenic properties; however, recent case reports have raised safety concerns, primarily involving non-standardised or multi-ingredient formulations. This systematic review evaluated the safety and tolerability of SARE in healthy adults, with a focus on clinical biomarkers and adverse event reporting. Methods: Randomised trials were identified through searches of PubMed, Web of Science and Google Scholar, published from 2010 to April 2026. Studies administering single-ingredient, standardised root-only extracts to generally healthy populations were included. Risk of bias was assessed using the Cochrane RoB 2 tool. Results: Twenty-three studies with a total of 2317 participants met the inclusion criteria, with doses ranging from 125 to 600 mg/day and intervention durations from a single dose to 180 days. Across studies, hepatic, renal, haematological, endocrine, and cardiovascular biomarkers remained within normal clinical ranges, with no clinically meaningful adverse alterations reported. Reductions in cortisol were consistently observed, while increases in testosterone remained within physiological ranges. No serious adverse events attributable to SARE were reported. Mild adverse events, including gastrointestinal discomfort, headache, and transient drowsiness, were infrequently reported and occurred in both intervention and comparator groups. Conclusions: SARE was well tolerated in healthy adults at the studied doses and durations. However, limited long-term data (>180 days) and heterogeneity in study design and reporting warrant further large-scale, standardised trials to confirm safety across extended use and diverse populations. The review is registered in the PROSPERO database with ID CRD420261337116.
- Open Access
Ashwagandha Root Extract Stabilises Physiological Stress Responses in Male and Female Team Sports Athletes During Pre-Season Training
Objectives: This study investigates the effects of 600 mg/day Ashwagandha root extract on physiological stress biomarkers, perception of recovery, muscle strength and aerobic capacity in team sports athletes during pre-season training, a period associated with elevated cortisol and accumulated training stress. Methods: Fifty-six athletes (26.8 ± 4.4 years, 1.74 ± 0.10 m, 79.4 ± 17.3 kg, 11.0 ± 7.1 career years) across rugby, water polo and football were randomly assigned to an Ashwagandha (ASH; n = 28, 14 males and 14 females) or placebo (PLA; n = 28, 14 males and 14 females) group for 42 days. Salivary biomarkers were assessed after training, muscle strength and aerobic capacity were measured during training, and perception of recovery was evaluated with Hooper Index (HI) the following day. Mixed ANOVA was used to determine group × time interactions and Bonferroni post hoc analyses were conducted for multiple pairwise comparisons. Results: In female athletes, salivary cortisol increased significantly in PLA (p = 0.001), while recovery parameters such as the overall HI score (p = 0.001), Delayed Onset Muscle Soreness (DOMS) (p = 0.008) and perception of fatigue (p = 0.026) scores improved significantly in ASH. In males, salivary cortisone increased significantly in PLA (p = 0.022), while Countermovement Jump (CMJ) improved significantly in ASH (p = 0.018). Pull-up performance increased in both PLA (p = 0.004) and ASH (p < 0.0001) in males. Conclusions: Supplementation with 600 mg/day of Ashwagandha root extract for 42 days may stabilise stress biomarkers, improve perception of recovery and enhance muscle strength in team sports athletes during pre-season training. The trial is registered on ClinicalTrials.gov with the ID NCT07041853.
Open AccessAshwagandha Root Extract Stabilises Physiological Stress Responses in Male and Female Team Sports Athletes During Pre-Season Training
Objectives: This study investigates the effects of 600 mg/day Ashwagandha root extract on physiological stress biomarkers, perception of recovery, muscle strength and aerobic capacity in team sports athletes during pre-season training, a period associated with elevated cortisol and accumulated training stress. Methods: Fifty-six athletes (26.8 ± 4.4 years, 1.74 ± 0.10 m, 79.4 ± 17.3 kg, 11.0 ± 7.1 career years) across rugby, water polo and football were randomly assigned to an Ashwagandha (ASH; n = 28, 14 males and 14 females) or placebo (PLA; n = 28, 14 males and 14 females) group for 42 days. Salivary biomarkers were assessed after training, muscle strength and aerobic capacity were measured during training, and perception of recovery was evaluated with Hooper Index (HI) the following day. Mixed ANOVA was used to determine group × time interactions and Bonferroni post hoc analyses were conducted for multiple pairwise comparisons. Results: In female athletes, salivary cortisol increased significantly in PLA (p = 0.001), while recovery parameters such as the overall HI score (p = 0.001), Delayed Onset Muscle Soreness (DOMS) (p = 0.008) and perception of fatigue (p = 0.026) scores improved significantly in ASH. In males, salivary cortisone increased significantly in PLA (p = 0.022), while Countermovement Jump (CMJ) improved significantly in ASH (p = 0.018). Pull-up performance increased in both PLA (p = 0.004) and ASH (p < 0.0001) in males. Conclusions: Supplementation with 600 mg/day of Ashwagandha root extract for 42 days may stabilise stress biomarkers, improve perception of recovery and enhance muscle strength in team sports athletes during pre-season training. The trial is registered on ClinicalTrials.gov with the ID NCT07041853.
- Top Cited PapersOpen Access
- 15 February 2025
- Published by Wiley in European Journal of Sport Science
- Vol. 25 (3) , e12265
Effects of Root Extract of Ashwagandha (Withania somnifera) on Perception of Recovery and Muscle Strength in Female Athletes
Ashwagandha is a supplement with the potential to improve exercise performance. However, research on its impact on female athletes remains limited. This study investigates the effects of ashwagandha on exercise recovery and muscle strength in professional female athletes, addressing a gap in understanding its role in this underrepresented population. Female footballers were randomly assigned to a 600 mg/day ashwagandha root extract group (ASH, n = 15; age: 26.0 ± 4.9 years, height: 1.66 ± 0.1 m, body mass: 61.5 ± 7.5 kg, and career: 15.2 ± 7.4 years) or a placebo group (PLA, n = 15; age: 23.5 ± 5.5 years, height: 1.66 ± 0.1 m, body mass: 61.5 ± 6.0 kg, and career: 13.1 ± 4.9 years). Recovery was assessed with total quality recovery (TQR), Hooper Index (HI) and rate of perceived exertion (RPE). Strength was assessed by hand grip, medicine ball throw (MBT), countermovement jump (CMJ) and peak power. Dietary intake was recorded prior to baseline measurements. Repeated measures ANOVA, Bonferroni test, independent t‐tests and ANCOVA were used in the analysis. A significant group × time interaction effect was found for TQR (p = 0.026), with the post‐hoc analysis revealing a significant difference between ASH and PLA at 28 days (p = 0.039). Perceived sleep quality from HI improved significantly in ASH compared to PLA (p = 0.038), with a significant change at 14 days. The ANCOVA analysis highlighted the significant influence of carbohydrate intake on hand grip strength (p = 0.005), MBT (p < 0.001) and body mass (p < 0.001). A dosage of 600 mg of ashwagandha root extract for 28 days may improve TQR and enhance perceived sleep quality in female footballers. Future research should investigate the optimal dosage and test across a broader range of athletic populations.Trials Registration: The trial is registered on ClinicalTrials.gov with the ID NCT06264986
- 15 February 2025
- Published by Wiley in European Journal of Sport Science
- Vol. 25 (3) , e12265
Top Cited PapersOpen AccessEffects of Root Extract of Ashwagandha (Withania somnifera) on Perception of Recovery and Muscle Strength in Female Athletes
Ashwagandha is a supplement with the potential to improve exercise performance. However, research on its impact on female athletes remains limited. This study investigates the effects of ashwagandha on exercise recovery and muscle strength in professional female athletes, addressing a gap in understanding its role in this underrepresented population. Female footballers were randomly assigned to a 600 mg/day ashwagandha root extract group (ASH, n = 15; age: 26.0 ± 4.9 years, height: 1.66 ± 0.1 m, body mass: 61.5 ± 7.5 kg, and career: 15.2 ± 7.4 years) or a placebo group (PLA, n = 15; age: 23.5 ± 5.5 years, height: 1.66 ± 0.1 m, body mass: 61.5 ± 6.0 kg, and career: 13.1 ± 4.9 years). Recovery was assessed with total quality recovery (TQR), Hooper Index (HI) and rate of perceived exertion (RPE). Strength was assessed by hand grip, medicine ball throw (MBT), countermovement jump (CMJ) and peak power. Dietary intake was recorded prior to baseline measurements. Repeated measures ANOVA, Bonferroni test, independent t‐tests and ANCOVA were used in the analysis. A significant group × time interaction effect was found for TQR (p = 0.026), with the post‐hoc analysis revealing a significant difference between ASH and PLA at 28 days (p = 0.039). Perceived sleep quality from HI improved significantly in ASH compared to PLA (p = 0.038), with a significant change at 14 days. The ANCOVA analysis highlighted the significant influence of carbohydrate intake on hand grip strength (p = 0.005), MBT (p < 0.001) and body mass (p < 0.001). A dosage of 600 mg of ashwagandha root extract for 28 days may improve TQR and enhance perceived sleep quality in female footballers. Future research should investigate the optimal dosage and test across a broader range of athletic populations.Trials Registration: The trial is registered on ClinicalTrials.gov with the ID NCT06264986